Thomas Birkballe Hansen

Company: Targovax

Job title: Vice President of Research

Seminars:

Combining Adenovirus Oncolytic Therapy With Circular RNAs: Future Perspectives Based on Clinical Experience 2:30 pm

Demonstrating promising clinical efficacy and capacity to increase tumor infiltration on anti PD-1-resistant advanced melanoma Providing clinical efficacy of ONCOS-102 correlated with virus persistence in the tumor and stable remodelling of the tumor microenvironment Harnessing expression of highly stable circular RNAs encoding additional immuno-modulatory payloads to further increase efficacy of oncolytic adenovirusesRead more

day: Day One